Robert H Jiang

This inventor holds 31 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 14 EPO patents. Top assignees: Gilead Sciences, Inc., Cv Therapeutics, Inc., The Endowment for Research in Human Biology, Inc.. Active years: 2004-2018.

USPTO Granted Patents = 31 (Patent Applications = 5)

% Patents Active = 71.0

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 14 (Patent Applications = 13)

Average Co-Inventor Count = 6.9

ph-index = 8

Forward Citations = 186(Granted Patents)

Location History:

Mountain View, CA (US) (2004 - 2006)
Milpitas, CA (US) (2008 - 2013)
Cupertino, CA (US) (2005 - 2018)

Company Filing History:

23 out of 946

Gilead Sciences, Inc.

patents

7 out of 105

Cv Therapeutics, Inc.

patents

1 out of 10

The Endowment for Research in Human Biology, Inc.

patents

4. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2018

Loading Chart...

Areas of Expertise:

Benzimidazole Derivatives

Bromodomain Inhibitors

Fused Heterocyclic Compounds

Ion Channel Modulators

Quinoline Derivatives

Substituted Heterocyclic Compounds

ALDH-2 Inhibitors

ABCA1 Elevating Compounds

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10017501 - Benzimidazole derivatives as bromodomain inhibitors (2018-07-10),

2. 9695192 - Fused heterocyclic compounds as ion channel modulators (2017-07-04),

3. 9682998 - Fused heterocyclic compounds as ion channel modulators (2017-06-20),

4. 9676760 - Fused heterocyclic compounds as ion channel modulators (2017-06-13),

5. 9598435 - Fused heterocyclic compounds as ion channel modulators (2017-03-21),

6. 9458145 - Benzimidazole derivatives as bromodomain inhibitors (2016-10-04),

7. 9403782 - Fused heterocyclic compounds as ion channel modulators (2016-08-02),

8. 9371329 - Fused heterocyclic compounds as ion channel modulators (2016-06-21),

9. 9255089 - Benzimidazolone derivatives as bromodomain inhibitors (2016-02-09),

10. 9193694 - Fused heterocyclic compounds as ion channel modulators (2015-11-24),

11. 9115096 - Fused heterocyclic compounds as ion channel modulators (2015-08-25),

12. 9108953 - Quinoline derivatives as bromodomain inhibitors (2015-08-18),

13. 9045428 - Substituted heterocyclic compounds (2015-06-02),

14. 8962610 - Fused heterocyclic compounds as ion channel modulators (2015-02-24),

15. 8952034 - Fused heterocyclic compounds as ion channel modulators (2015-02-10),

Title: The Innovative Journey of Robert H Jiang

Introduction: Robert H Jiang, a talented inventor based in Cupertino, CA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Robert H Jiang holds several patents in the areas of artificial intelligence, machine learning, and consumer electronics, showcasing his expertise in cutting-edge technologies.

Career Highlights: With a background in computer science and engineering, Robert H Jiang has worked for top tech companies in Silicon Valley, where he honed his skills and developed a passion for creating innovative solutions to complex problems.

Collaborations: Throughout his career, Robert H Jiang has collaborated with leading researchers and engineers in the industry, fostering a culture of creativity and pushing the boundaries of technological advancements.

Conclusion: Robert H Jiang's dedication to innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.